Vaccines
RSSArticles
-
EDs Boost COVID-19 Vaccination Efforts
Some emergency providers may view COVID-19 vaccinations as another task piled on an already-full plate. However, EDs are uniquely positioned to reach many underserved and high-risk populations that have yet to receive protection from COVID-19. -
National Orgs Back COVID-19 Vaccine Mandates for Healthcare Workers
Groups call for action as cases and hospitalizations surge again. -
Vaccines Are Available, but the Search for COVID-19 Therapeutics Continues
Right after the FDA issued an emergency use authorization for one drug, feds pressed pause on distributing another. -
Texas Judge Tosses Suit Over COVID-19 Vaccine Mandate
Plaintiffs expected to challenge ruling in ongoing saga over Houston facility’s policy. -
The Cost-Effectiveness of HPV Vaccination for Adults Age 30 to 45 Years
Researchers found extending the upper limit of HPV vaccination to age 30 to 45 years is not cost-effective. -
FDA, CDC Back COVID-19 Vaccine for Adolescents
The Pfizer/BioNTech solution will be available for Americans age 12 to 15 years. -
Controversy Developing Over Vaccine Passports
Concerns are emerging about individual rights, equal access, and how anyone would enforce mandates.
-
U.S. Supports Waiving Intellectual Property Protections for COVID-19 Vaccines
The aim is to accelerate the spread of shots around the globe.
-
White Adults, Women Overrepresented in U.S. Vaccine Trials
Investigators uncover reporting gaps, lack of proper representation for older adults, minority groups.
-
Herpes Zoster Vaccine: Effective but Underused
The adjuvanted recombinant herpes zoster vaccine is highly effective in practice, but it is vastly underused.